Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2002
12/31/2002US6500674 Method for the diagnosis of brain/neurological disease using monoclonal antibodies specific for PHF-tau, hybridomas secreting them, and antigen recognition by these antibodies and their applications
12/31/2002US6500672 A competitive assay for binding activity to recombinant hepatocyte nuclear factor-4 receptors, a chimeric receptor comprising the ligand binding domain of a hnf-4 receptor and dna binding domain of another receptor
12/31/2002US6500664 Growth differentiation factor-8 family nucleic acid sequences
12/31/2002US6500659 A thermostable enzyme that catalyzes the removal of arginine, phenylalanine, or methionine from the n-terminal end of peptides
12/31/2002US6500654 Cardiac-related ankyrin-repeat protein kinase
12/31/2002US6500653 Nucleic acids and polypeptides which resemble RHO and which interact with cell signaling pathways and proteins
12/31/2002US6500642 Mammalian cdna which encodes a mammalian mapop-3. it also provides for the use of the cdna, fragments, complements, and variants thereof and of the encoded protein, portions thereof and antibodies thereto for diagnosis and treatment of breast
12/31/2002US6500638 Nucleotide sequences for use in the diagnosis and treatment of prostate cancer
12/31/2002US6500635 Insulin-like growth factor binding protein (IGFBF-5)
12/31/2002US6500634 Neurotransmission by excitatory amino acids (eaas) such as glutamate is mediated via membrane-bound surface receptors. dna coding for eaa receptors of one family of human nmda-binding type receptors has now been isolated and receptor
12/31/2002US6500624 Kainate-binding, human CNS receptors of the EAA3 family
12/31/2002US6500431 Inhibitors of angiogenesis and tumor growth
12/31/2002US6500428 Antibodies to a lymphocyte surface receptor that binds CAML and methods of use thereof
12/31/2002US6500417 Mutants of interleukin-3, containing one or more deletions and/or one or more substitutions, with interesting pharmacological properties as interleukin-3 antagonist
12/31/2002CA2069460C Methods and compositions for preparation and use of a herpes protease
12/27/2002WO2002103362A2 Cancer associated protein
12/27/2002WO2002103359A1 NUCLEAR ENVELOPE PROTEIN RECOGNIZED BY ATYPICAL p-ANCA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND AUTOIMMUNE LIVER DISEASES
12/27/2002WO2002103033A1 Method of detecting and separating undifferentiated liver cellss using dlk
12/27/2002WO2002103029A2 Methods for sterilizing preparations of monoclonal immunoglobulins
12/27/2002WO2002103016A2 Human tachykinin-related splice variants and compositions thereof
12/27/2002WO2002103002A2 Gene associated with leishmania parasite virulence
12/27/2002WO2002102990A2 Fibroblast growth factor and nucleic acid encoding same
12/27/2002WO2002102987A2 Methods and compositions based on protein interactions with mastermind
12/27/2002WO2002102985A2 Pate, a gene expressed in prostate cancer, prostate and testis, and uses thereof
12/27/2002WO2002102984A2 Hdac9 polypeptides and polynucleotides and uses thereof
12/27/2002WO2002102975A2 Dna molecules and recombinant dna molecules for producing humanized monoclonal antibodies to s. mutans
12/27/2002WO2002102974A2 Mutant proteins, high potency inhibitory antibodies and fimch crystal structure
12/27/2002WO2002102973A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
12/27/2002WO2002102972A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
12/27/2002WO2002102855A2 In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
12/27/2002WO2002102854A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
12/27/2002WO2002102853A2 Cd4-specific antibody trx1 and uses therefor
12/27/2002WO2002102839A2 Novel g-protein coupled receptors and dna sequences thereof
12/27/2002WO2002102837A2 Marker for identifying hematopoietic stem cells
12/27/2002WO2002102832A1 Use of fragments of oxytocin for the preparation of a pharmaceutical composition in order to create eustasis
12/27/2002WO2002102829A2 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
12/27/2002WO2002102408A1 Moraxella bovis cytotoxin, cytotoxin gene, antibodies and vaccines for prevention and treatment of moraxella bovis infections
12/27/2002WO2002102320A2 Fce fusion proteins for treatment of allergy and asthma
12/27/2002WO2002102312A2 Combination therapy of gamma-interferon and b cell specific antibodies
12/27/2002WO2002102310A2 Proteins associated with cell growth, differentiation, and death
12/27/2002WO2002102306A2 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy
12/27/2002WO2002102303A2 Crystals and structure of synagis fab
12/27/2002WO2002102299A2 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
12/27/2002WO2002102235A2 Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
12/27/2002WO2002102229A2 Diagnosing tumorigenicity and determining resistance to anticancer therapy
12/27/2002WO2002074071A3 Transgenic animal model of ige-mediated allergic responses
12/27/2002WO2002057302A3 A virus causing respiratory tract illness in susceptible mammals
12/27/2002WO2002056907A3 Molecular antigen array presenting amyloid beta
12/27/2002WO2002056831A9 Immunogenic proteoliposomes, and uses thereof
12/27/2002WO2002051994A3 Polypeptides
12/27/2002WO2002040545A3 Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the fv to lower the isoelectric point
12/27/2002WO2002038795A3 Braf35 protein and brca2/braf35 complex and methods of use
12/27/2002WO2002036635A3 Monoclonal antibodies for assaying lipid transfer proteins
12/27/2002WO2002018445A8 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
12/27/2002WO2002012467A3 Drug metabolizing enzymes
12/27/2002WO2002012279A3 Schizophrenia related gene and protein
12/27/2002WO2002008257A3 Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof
12/27/2002WO2002004514A8 Compositions and methods for the therapy and diagnosis of lung cancer
12/27/2002WO2001096390A3 Compositions and methods for the therapy and diagnosis of colon cancer
12/27/2002WO2001094587A3 Extracellular messengers
12/27/2002WO2001085937A3 Regulator of g protein signalling (rgs8)
12/27/2002WO2001085905A3 Isolated gum operon from xyllela fastidiosa, isolated nucleic acid molecules therefrom, and uses thereof
12/27/2002WO2001079300A9 Surface-bound antigen binding portions of antibodies that bind to ctla-4 and cd28 and uses therefor
12/27/2002WO2001074903A9 Cd20/ige-receptor like molecules and uses thereof
12/27/2002CA2465075A1 Hdac9 polypeptides and polynucleotides and uses thereof
12/27/2002CA2455387A1 Fce fusion proteins for treatment of allergy and asthma
12/27/2002CA2451465A1 Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
12/27/2002CA2450793A1 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
12/27/2002CA2450757A1 Methods for detection and separation of undifferentiated hepatic cells using dlk
12/27/2002CA2450730A1 Methods for sterilizing preparations of monoclonal immunoglobulins
12/27/2002CA2450700A1 Trx1 antibody and uses therefor
12/27/2002CA2450666A1 Diagnosing tumorigenicity and determining resistance to anticancer therapy
12/27/2002CA2450590A1 Methods and compositions for inhibiting, preventing or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy
12/27/2002CA2450067A1 Proteins associated with cell growth, differentiation, and death
12/27/2002CA2448506A1 Dna molecules and recombinant dna molecules for producing humanized monoclonal antibodies to s. mutans
12/27/2002CA2446285A1 Fibroblast growth factor and nucleic acid encoding same
12/27/2002CA2445261A1 Human tachykinin-related splice variants and compositions thereof
12/26/2002US20020199214 Avian lysozyme promoter
12/26/2002US20020199213 Transgenic transchromosomal rodents for making human antibodies
12/26/2002US20020198367 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof
12/26/2002US20020198366 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/26/2002US20020198365 Antibody for use in prevention of prokaryote infections
12/26/2002US20020198360 Structural models for cytoplasmic domains of transmembrane receptors
12/26/2002US20020198263 Preventing or treating deficiency by administering l-carnitine or a salt
12/26/2002US20020198166 Method for treatment of cancer and infectious diseases and compositions useful in same
12/26/2002US20020198149 Polypeptides fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides; native membrane-bound proteins; PRO polypeptides
12/26/2002US20020198148 Polypeptides fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides; native membrane-bound proteins; PRO polypeptides
12/26/2002US20020198147 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/26/2002US20020198143 B7-like polynucleotides, polypeptides, and antibodies
12/26/2002US20020197723 Assessment of cervical cells
12/26/2002US20020197716 Modified rapid expansion methods ("modified-REM") for in vitro propagation of T lymphocytes
12/26/2002US20020197712 Polypeptide for use as tools in analyzing enzymatic gene expression
12/26/2002US20020197704 Nucleotide sequences coding enzymatic polypeptide for use as tool in genetic engineering
12/26/2002US20020197700 Receptor of the EDb-fibronectin domains
12/26/2002US20020197694 Compositon for use in the detection of preferential particles in solution
12/26/2002US20020197693 Novel molecules of the card-related protein family and uses thereof
12/26/2002US20020197681 Identification and uses of a hyaluronan receptor for endocytosis
12/26/2002US20020197677 Nucleotide squences coding preferential antibody for prevention of and treatment of infections
12/26/2002US20020197676 Novel chromophores/fluorophores and methods for using the same
12/26/2002US20020197675 Glial nerovus system modulator for use in the treatment of nervous system disorders and spine damage
1 ... 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 ... 1494